Skin lesions - an indicator of disease activity in systemic lupus erythematosus?

被引:52
作者
Zecevic, RD
Vojvodic, D
Ristic, B
Pavlovic, MD
Stefanovic, D
Karadaglic, D
机构
[1] Mil Med Acad, Dept Dermatol, YU-11002 Belgrade, Yugoslavia
[2] Mil Med Acad, Inst Med Res, YU-11002 Belgrade, Yugoslavia
[3] Mil Med Acad, Dept Rheumatol & Clin Immunol, YU-11002 Belgrade, Yugoslavia
关键词
systemic lupus erythematosus; skin lesions; SLEDAI;
D O I
10.1191/096120301675962535
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cutaneous manifestations have great diagnostic value for systemic lupus erythematosus (SLE). In this study we tried to establish a correlation between lupus erythematosus LE-specific and LE-nonspecific cutaneous lesions and disease activity measured by the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI). Sixty-six patients with SLE were evaluated. They were divided into three groups having: (1) only LE-specific lesions (38 or 58.46%); (2) only LE-nonspecific lesions (4 or 6.15%); and (3) both types of lesions (23 or 35.38%). Results were analyzed using the Student t-test. Patients with LE-nonspecific skin manifestations had significantly increased disease activity compared to those with only LE-specific lesions. The number of different skin lesion types also correlated with disease activity. It was significantly increased in a group with three different types of lesion, either specific or nonspecific. Patients with only one type of lesion had mild disease. An intermediate disease activity was found in the group with two different lesion types. Lupus-specific skin manifestations serve primarily as an important diagnostic clue. In conclusion, patients with LE-nonspecific lesions have significantly more active SLE than those with LE-specific lesions and may therefore require more intensive therapy and disease monitoring.
引用
收藏
页码:364 / 367
页数:4
相关论文
共 14 条
  • [1] DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS
    BOMBARDIER, C
    GLADMAN, DD
    UROWITZ, MB
    CARON, D
    CHANG, CH
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (06): : 630 - 640
  • [2] GILLIAM JN, 1982, CLIN RHEUM DIS, V8, P207
  • [3] JABLONSKA S, 1993, CLIN DERMATOL, V11, P253
  • [4] Magro CM, 1996, BRIT J DERMATOL, V134, P855
  • [5] MIJAILOVIC B, 1979, ACTA DERM-VENEREOL, V6, P95
  • [6] IMMUNOPATHOLOGIC STUDIES OF CUTANEOUS LUPUS-ERYTHEMATOSUS
    PROVOST, TT
    REICHLIN, M
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1988, 8 (04) : 223 - 233
  • [7] THE RELATIONSHIP BETWEEN DISCOID AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    PROVOST, TT
    [J]. ARCHIVES OF DERMATOLOGY, 1994, 130 (10) : 1308 - 1310
  • [8] SONTHEIMER RD, 1996, J AM ACAD DERMATOL, V34, P830
  • [9] CUTANEOUS MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS
    TUFFANELLI, DL
    DUBOIS, EL
    [J]. ARCHIVES OF DERMATOLOGY, 1964, 90 (04) : 377 - &
  • [10] Epitope spreading
    Vanderlugt, CJ
    Miller, SD
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (06) : 831 - 836